Clinical Trials Arena October 16, 2023
The US government’s Covid-19 research programme has announced the vaccine candidates for its latest round of funding.
US Covid-19 research initiative Project NextGen is continuing apace, announcing on Friday (13 October) that the Department for Health and Human Services (HHS) had selected its initial next-generation vaccine candidates for $500m in awards.
Project NextGen is the follow-up to Operation Warp Speed, the $18bn Covid vaccine development programme. Though smaller in scope, this grant brings the total funding of NextGen to around $2bn following August’s $1.4bn award.
The vaccine candidates come from three relatively small companies and have received proportionately small funding amounts: $8.5m to CastleVax, which is developing a vector-based intranasal vaccine, and $10m to Codagenix and Gritstone Bio, working on...
Today's Sponsors
Today's Sponsor